NICE coronavirus guidelines on gastrointestinal and liver conditions and acute myocardial injuries
NICE has published two new rapid coronavirus guidelines on the care of patients with suspected and confirmed COVID-19. They cover the management of disorders of...
IQVIA collaborates to launch accelerated COVID-19 infection survey
IQVIA has joined forces with the Office for National Statistics (ONS), Oxford University and UK Biocentre to launch an accelerated COVID-19 infection survey. They will...
Government launches coronavirus vaccine taskforce as human clinical trials start
The UK Government has launched a new coronavirus vaccine taskforce to drive forward, expedite and co-ordinate efforts to research and then produce a coronavirus vaccine....
NICE recommends VITRAKVI® for children and adults with TRK fusion driven cancer
Bayer announced that VITRAKVI® (larotrectinib) was recommended by the National Institute for Health and Care Excellence (NICE) for the treatment of advanced neurotrophic tyrosine...
Coronavirus convalescent plasma wanted for clinical trial
The NHS Blood and Transplant Service is asking for people who’ve recovered from coronavirus (COVID-19) to donate blood plasma, as part of a potential clinical...
Novartis sponsors hydroxychloroquine clinical trial in hospitalised COVID-19 patients
Novartis has announced that it is to sponsor a large hydroxychloroquine clinical trial in hospitalised COVID-19 patients. Novartis has reached an agreement with the US...
MHRA fast track nod for UK pharma company’s COVID-19 study
4D pharma has received expedited acceptance from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to commence a Phase II study of MRx-4DP0004...
Roche develops new COVID-19 antibody test
Roche has announced the development and upcoming launch of a new COVID-19 antibody test. Its Elecsys® Anti-SARS-CoV-2 serology test will detect antibodies in people...
Cegedim launches free pharmacist training during COVID-19
Cegedim launches free digital training to help pharmacists deliver ongoing care throughout COVID-19. Cegedim Rx, part of the innovative healthcare technology and services company, Cegedim,...
Celltrion identify 14 antibodies that neutralise COVID-19 virus
Celltrion Group has successfully selected the most potent antibody candidates to neutralise COVID-19 virus, SARS-CoV-2. Through a partnership with the Korea Centers for Disease Control...
Latest articles
Reducing time to market for new COVID-19 vaccines
With the target set to offer a COVID-19 vaccine to a further 17.7 million people in the next five priority groups - including all...
NHS gives women Human Papillomavirus Virus (HPV) home testing kits
NHS England has announced that more than 31,000 women will be offered kits to carry out HPV self-sampling in the privacy and convenience of...
Tribunal upholds CMA decision on pharma collusion and £1.2m fine
The Competition Appeal Tribunal has upheld the Competition and Markets Authority (CMA)’s finding that pharmaceutical firm Lexon broke competition law, dismissing Lexon’s appeal. Last year,...
Popular articles
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
NHS prescription charge to increase from 1 April 2021
The NHS prescription charge will increase to £9.35 per prescription item from 1 April 2021 in England, according to the Pharmaceutical Services Negotiating Committee...
NHS gives women Human Papillomavirus Virus (HPV) home testing kits
NHS England has announced that more than 31,000 women will be offered kits to carry out HPV self-sampling in the privacy and convenience of...
Tribunal upholds CMA decision on pharma collusion and £1.2m fine
The Competition Appeal Tribunal has upheld the Competition and Markets Authority (CMA)’s finding that pharmaceutical firm Lexon broke competition law, dismissing Lexon’s appeal. Last year,...